National Biodefense Science Board; Call for Nominees, 35035 [2013-13832]

Download as PDF Federal Register / Vol. 78, No. 112 / Tuesday, June 11, 2013 / Notices provide identity documents sufficient to satisfy the custodian of the records that the requester is entitled to access. RECORD ACCESS PROCEDURES: Individuals wishing to access their own records should contact the system manager at the address above. CONTESTING RECORD PROCEDURES: Rules for contesting the content of a record and appealing a decision are contained in 41 CFR 105–64. RECORD SOURCE CATEGORIES: The sources for information in the system are the individuals about whom the records are maintained, the supervisors of those individuals, existing GSA systems, a sponsoring agency, a former sponsoring agency, other Federal agencies, contract employers, or former employers. [FR Doc. 2013–13813 Filed 6–10–13; 8:45 am] BILLING CODE 6820–34–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Biodefense Science Board; Call for Nominees Office of the Secretary, Department of Health and Human Services. ACTION: Notice. wreier-aviles on DSK5TPTVN1PROD with NOTICES AGENCY: SUMMARY: The Office of the Secretary is accepting application submissions from qualified individuals who wish to be considered for membership on the National Biodefense Science Board (NBSB). Six members have membership expiration dates of December 31, 2013; therefore six new voting members will be selected for the Board. Nominees are being accepted in the following categories: Industry, Academia, Healthcare Consumer Organizations, and Organizations Representing Other Appropriate Stakeholders. Please visit the NBSB Web site at www.phe.gov/ nbsb for all application submission information and instructions. The deadline for all application submissions is July 7, 2013, at 11:59 p.m. FOR FURTHER INFORMATION CONTACT: CAPT Charlotte Spires, DVM, MPH, DACVPM, Executive Director and Designated Federal Official, National Biodefense Science Board, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Thomas P. O’Neill Federal Building, Room number 14F18, 200 C St. SW., Washington, DC 20024; Office: 202–260–0627, Email address: charlotte.spires@hhs.gov. VerDate Mar<15>2010 15:13 Jun 10, 2013 Jkt 229001 Pursuant to section 319M of the Public Health Service Act (42 U.S.C. 247d–7f) and section 222 of the Public Health Service Act (42 U.S.C. 217a), the Department of Health and Human Services established the National Biodefense Science Board. The Board shall provide expert advice and guidance to the Secretary on scientific, technical, and other matters of special interest to the Department of Health and Human Services regarding current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate. The Board may also provide advice and guidance to the Secretary and/or the Assistant Secretary for Preparedness and Response (ASPR) on other matters related to public health emergency preparedness and response. Description of Duties: The Board shall advise the Secretary and/or ASPR on current and future trends, challenges, and opportunities presented by advances in biological and life sciences, biotechnology, and genetic engineering with respect to threats posed by naturally occurring infectious diseases and chemical, biological, radiological, and nuclear agents. At the request of the Secretary and/or ASPR, the Board shall review and consider any information and findings received from the working groups established under 42 U.S.C. 247d–7f(b). At the request of the Secretary and/or ASPR, the Board shall provide recommendations and findings for expanded, intensified, and coordinated biodefense research and development activities. Additional advisory duties concerning public health emergency preparedness and response may be assigned at the discretion of the Secretary and/or ASPR. Structure: The Board shall consist of 13 voting members, including the Chairperson; additionally, there may be non-voting ex officio members. Pursuant to 42 U.S.C. 247d–7f(a), members and the chairperson shall be appointed by the Secretary from among the Nation’s preeminent scientific, public health and medical experts, as follows: (a) Such federal officials as the Secretary determines are necessary to support the functions of the Board, (b) four individuals from the pharmaceutical, biotechnology and device industries, (c) four academicians, and (d) five other members as determined appropriate by the Secretary and/or ASPR, one of whom must be a practicing health care professional, one of whom must be from an organization representing health care consumers, one of whom must have pediatric subject matter expertise, and one of whom shall be a State, tribal, territorial, or local public health official. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 35035 Additional members for category (d), above, will be selected from among emergency medical responders and organizations representing other appropriate stakeholders. A member of the Board described in (b), (c), and (d) in the above paragraph shall serve for a term of 3 years, except that the Secretary may adjust the terms of the initial Board appointees in order to provide for a staggered term of appointment of all members. Members who are not fulltime or permanent part-time federal employees shall be appointed by the Secretary as Special Government Employees. Dated: June 4, 2013. Nicole Lurie, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services. [FR Doc. 2013–13832 Filed 6–10–13; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial review The meeting announced below concerns Centers for Disease Control and Prevention Public Health Preparedness and Response Research to Aid Recovery from Hurricane Sandy, Request for Application (RFA) TP13– 001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 8:30 a.m.–5:00 p.m., July 10, 2013 (Closed); 8:30 a.m.–5:00 p.m., July 11, 2013 (Closed). Place: Georgian Terrace Hotel, 659 Peachtree Street NE., Atlanta, Georgia 30308. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Centers for Disease Control and Prevention Public Health Preparedness and Response Research to Aid Recovery from Hurricane Sandy, RFA TP13–001’’. E:\FR\FM\11JNN1.SGM 11JNN1

Agencies

[Federal Register Volume 78, Number 112 (Tuesday, June 11, 2013)]
[Notices]
[Page 35035]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13832]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Biodefense Science Board; Call for Nominees

AGENCY: Office of the Secretary, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Office of the Secretary is accepting application 
submissions from qualified individuals who wish to be considered for 
membership on the National Biodefense Science Board (NBSB). Six members 
have membership expiration dates of December 31, 2013; therefore six 
new voting members will be selected for the Board. Nominees are being 
accepted in the following categories: Industry, Academia, Healthcare 
Consumer Organizations, and Organizations Representing Other 
Appropriate Stakeholders. Please visit the NBSB Web site at 
www.phe.gov/nbsb for all application submission information and 
instructions. The deadline for all application submissions is July 7, 
2013, at 11:59 p.m.

FOR FURTHER INFORMATION CONTACT: CAPT Charlotte Spires, DVM, MPH, 
DACVPM, Executive Director and Designated Federal Official, National 
Biodefense Science Board, Office of the Assistant Secretary for 
Preparedness and Response, U.S. Department of Health and Human 
Services, Thomas P. O'Neill Federal Building, Room number 14F18, 200 C 
St. SW., Washington, DC 20024; Office: 202-260-0627, Email address: 
charlotte.spires@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to section 319M of the Public 
Health Service Act (42 U.S.C. 247d-7f) and section 222 of the Public 
Health Service Act (42 U.S.C. 217a), the Department of Health and Human 
Services established the National Biodefense Science Board. The Board 
shall provide expert advice and guidance to the Secretary on 
scientific, technical, and other matters of special interest to the 
Department of Health and Human Services regarding current and future 
chemical, biological, nuclear, and radiological agents, whether 
naturally occurring, accidental, or deliberate. The Board may also 
provide advice and guidance to the Secretary and/or the Assistant 
Secretary for Preparedness and Response (ASPR) on other matters related 
to public health emergency preparedness and response.
    Description of Duties: The Board shall advise the Secretary and/or 
ASPR on current and future trends, challenges, and opportunities 
presented by advances in biological and life sciences, biotechnology, 
and genetic engineering with respect to threats posed by naturally 
occurring infectious diseases and chemical, biological, radiological, 
and nuclear agents. At the request of the Secretary and/or ASPR, the 
Board shall review and consider any information and findings received 
from the working groups established under 42 U.S.C. 247d-7f(b). At the 
request of the Secretary and/or ASPR, the Board shall provide 
recommendations and findings for expanded, intensified, and coordinated 
biodefense research and development activities. Additional advisory 
duties concerning public health emergency preparedness and response may 
be assigned at the discretion of the Secretary and/or ASPR.
    Structure: The Board shall consist of 13 voting members, including 
the Chairperson; additionally, there may be non-voting ex officio 
members. Pursuant to 42 U.S.C. 247d-7f(a), members and the chairperson 
shall be appointed by the Secretary from among the Nation's preeminent 
scientific, public health and medical experts, as follows: (a) Such 
federal officials as the Secretary determines are necessary to support 
the functions of the Board, (b) four individuals from the 
pharmaceutical, biotechnology and device industries, (c) four 
academicians, and (d) five other members as determined appropriate by 
the Secretary and/or ASPR, one of whom must be a practicing health care 
professional, one of whom must be from an organization representing 
health care consumers, one of whom must have pediatric subject matter 
expertise, and one of whom shall be a State, tribal, territorial, or 
local public health official. Additional members for category (d), 
above, will be selected from among emergency medical responders and 
organizations representing other appropriate stakeholders. A member of 
the Board described in (b), (c), and (d) in the above paragraph shall 
serve for a term of 3 years, except that the Secretary may adjust the 
terms of the initial Board appointees in order to provide for a 
staggered term of appointment of all members. Members who are not 
fulltime or permanent part-time federal employees shall be appointed by 
the Secretary as Special Government Employees.

     Dated: June 4, 2013.
Nicole Lurie,
Assistant Secretary for Preparedness and Response, U.S. Department of 
Health and Human Services.
[FR Doc. 2013-13832 Filed 6-10-13; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.